Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

PIPTAZ-AFT POWDER FOR SOLUTION FOR INJECTION 4.5G/VIAL

Approval Number

SIN15482P

Drug Name

PIPTAZ-AFT POWDER FOR SOLUTION FOR INJECTION 4.5G/VIAL

Product Name

PIPTAZ-AFT POWDER FOR SOLUTION FOR INJECTION 4.5G/VIAL

Approval Date

May 11, 2018

Registrant

APEX PHARMA MARKETING PTE. LTD.

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

Registrant

APEX PHARMA MARKETING PTE. LTD.

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route of Administration

INTRAVENOUS

Medical Information

ATC Code

J01CR05

ATC Item Name

piperacillin and beta-lactamase inhibitor

Manufacturer Information

Pharmaceutical Manufacturer

APEX PHARMA MARKETING PTE. LTD.

Manufacturers

Shandong Anxin Pharmaceutical Co., Ltd. (Workshop 2100)

Active Ingredients

Ingredient Name

Tazobactam sodium 0.537g eqv. Tazobactam

Strength

0.5g

Drug MonographTazobactam

Ingredient Name

Piperacillin sodium 4.170g eqv. Piperacillin

Strength

4g

Drug MonographPiperacillin

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy